Nuvation Bio Prices $250 Million 0.75% Convertible Notes Due 2032, Repays $58.5 Million Loan
Nuvation Bio completed a registered offering of $250.0 million 0.75% Convertible Senior Notes due 2032, including a 30-day $37.5 million over-allotment option. The company also executed capped call transactions (initial cap price $10.4580 per share) intended to reduce dilution, and entered related…